Validation of Administrative Database Codes for Acute Kidney Injury in Kidney Transplant Recipients

Abstract

BackgroundValidation studies of acute kidney injury (AKI) diagnostic codes performed in the general population have shown poor sensitivity, but the accuracy of such codes in the kidney transplant population remains unknown.ObjectiveThe objective of this study is to determine the accuracy of AKI diagnostic codes in kidney transplant recipients. We hypothesized that the sensitivity of diagnostic codes would be significantly greater in the kidney transplant population since these patients are closely followed by nephrologists and are more likely to have serum creatinine measured.DesignThe design is a population-based retrospective cohort study using healthcare administrative and laboratory databases.SettingThe setting is in Southwestern Ontario and Ottawa, Ontario, Canada, from 2003 to 2012.PatientsWe included first-time kidney transplant recipients admitted to hospital for whom serum creatinine was measured in hospital and within 6 months prior (n = 524).MethodsPatients meeting the Acute Kidney Injury Network (AKIN) classification serum creatinine change criteria were classified as having AKI. We determined the sensitivity, specificity, and negative and positive predictive values for the ICD-10-CA code for AKI when present as an admission diagnosis, most responsible diagnosis, or any diagnosis compared to a reference standard of AKI defined by the AKIN criteria (stage 1 or greater, stage 2 or greater, or stage 3).ResultsForty-five percent of included kidney transplant patients had a diagnosis of AKI. The most sensitive coding algorithm (reference standard AKIN stage 2 or greater, ICD-10 code present as any diagnosis) had a sensitivity of 42.1 % (95 % CI 31.7, 53.3), a specificity of 90.6 % (95 % CI 87.6, 93.0), and a positive likelihood ratio of 4.5. The median (IQR) rise in serum creatinine from baseline in patients with and without AKI codes was 104 (57 to 158) μmol/L and 16 (−3 to 41) μmol/L, respectively (Mann-Whitney test, p < 0.0001).LimitationsThe low sensitivity of the AKI code may be due to an alternative diagnosis of acute rejection being assigned in certain cases. The cause of AKI could not be determined.ConclusionsSimilar to the general population, the ICD-10 N17x code misses many kidney transplant patients with AKI during their hospitalization. This makes the code unusable for studying the incidence and consequences of AKI in hospitalized kidney transplant patients.Electronic supplementary materialThe online version of this article (doi:10.1186/s40697-016-0108-7) contains supplementary material, which is available to authorized users.

Association of Nonsteroidal Anti-inflammatory Drug Prescriptions With Kidney Disease Among Active Young and Middle-aged Adults

“…One concern associated with diagnosis code validity could be case underdetection, 45 , 46 which may arise when procedure codes, such as for kidney transplantation, are entered rather than kidney disease codes. 47 This issue is likely less important in our study population because early and accurate identification of serious conditions is a key duty of military clinicians to ensure adherence to medical service standards for training and duty. 26 A diagnosis would usually occur well before advanced procedures, such as hemodialysis or transplantation, are required.…”

Effect of data validation audit on hospital mortality ranking and pay for performance

“…Keeping in mind that it was assessed by central recoders with their own potential biases, the overall quality of coding in our study was moderate, with significant variations between comorbidities (online supplementary table). Other studies for various specific indications such as venous thromboembolism,24 25 arrhythmia,26 stroke,27 hypersensitivity reactions,28 bone metastases,29 glaucoma,30 hip fractures,31 hidradenitis suppurativa,32 acute kidney injury,33 overdoses34 and sepsis19 35 have also found average validity, with significant variations between studies for the same condition 19 27 36. Under the French hospital payment system, patients with comorbidities are associated with higher payments to compensate for the higher burden of care, which may have favoured NPV over PPV and sensitivity over specificity.…”

Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands

“…As previously shown in the United Kingdom, the current study demonstrates a sufficient accuracy of nationwide-used diagnostic, procedural and medical treatment codes with chart review [ 19 ]. Other studies on comparisons of claims data with clinical registries show various results [ 20 – 22 ]. This is due to differences in medical specialisation, study purpose and database quality.…”